Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
EGFR Antibody (ICR10) - BSA Free, Novus Biologicals™

Rat Monoclonal Antibody
Supplier: Novus Biologicals NB6007240.025MG
Description
EGFR Monoclonal specifically detects EGFR in Human, Mouse samples. It is validated for Flow Cytometry, Immunohistochemistry, Immunoprecipitation, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Western Blot (Negative).Specifications
EGFR | |
Monoclonal | |
1.0 mg/mL | |
Flow Cytometry 1:50-1:100, Immunohistochemistry 1:10-1:500, Immunoprecipitation 1:10-1:500, Immunohistochemistry-Paraffin 1:10-1:500, Immunohistochemistry-Frozen 1:10-1:500, Western Blot (Negative) | |
P00533 | |
EGFR | |
Extracellular domain of Human EGF-receptor from head and neck carcinoma. | |
0.025 mg | |
Cancer, Cell Biology, Cell Cycle and Replication, Growth and Development, Hypoxia, Signal Transduction, Tumor Suppressors, Tyrosine Kinases | |
1956 | |
Mouse, Human | |
IgG2a |
Flow Cytometry, Immunohistochemistry (Frozen), Immunohistochemistry, Immunohistochemistry (Paraffin), Immunoprecipitation | |
ICR10 | |
Unconjugated | |
Phosphate buffered saline with 0.09% Sodium Azide | |
avian erythroblastic leukemia viral (v-erb-b) oncogene homolog, cell growth inhibiting protein 40, cell proliferation-inducing protein 61, EC 2.7.10, EC 2.7.10.1, epidermal growth factor receptor, epidermal growth factor receptor (avian erythroblastic leukemia viral (v-erb-b)oncogene homolog), ERBB, ErbB1, ERBB1PIG61, HER1, mENA, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1 | |
Rat | |
Ion exchange chromatography | |
RUO | |
Primary | |
EGFR. It does not react with erb-B2. | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction